Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
18922 | 464 | 41.6 | 92% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | PENTRAXIN 3 | Author keyword | 145 | 71% | 25% | 118 |
2 | PTX3 | Author keyword | 86 | 76% | 13% | 60 |
3 | PENTRAXIN | Author keyword | 12 | 31% | 7% | 33 |
4 | PENTRAXINS | Author keyword | 10 | 38% | 4% | 20 |
5 | NEURONAL PENTRAXIN 1 | Author keyword | 8 | 70% | 2% | 7 |
6 | PENTRAXIN3 | Author keyword | 5 | 54% | 2% | 7 |
7 | NEURONAL PENTRAXIN | Author keyword | 5 | 63% | 1% | 5 |
8 | PTX3 PROTEIN | Author keyword | 4 | 67% | 1% | 4 |
9 | L SACCO CLIN SCI | Address | 3 | 35% | 2% | 8 |
10 | SEZ PATOL IMMUNOL | Address | 3 | 100% | 1% | 3 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | PENTRAXIN 3 | 145 | 71% | 25% | 118 | Search PENTRAXIN+3 | Search PENTRAXIN+3 |
2 | PTX3 | 86 | 76% | 13% | 60 | Search PTX3 | Search PTX3 |
3 | PENTRAXIN | 12 | 31% | 7% | 33 | Search PENTRAXIN | Search PENTRAXIN |
4 | PENTRAXINS | 10 | 38% | 4% | 20 | Search PENTRAXINS | Search PENTRAXINS |
5 | NEURONAL PENTRAXIN 1 | 8 | 70% | 2% | 7 | Search NEURONAL+PENTRAXIN+1 | Search NEURONAL+PENTRAXIN+1 |
6 | PENTRAXIN3 | 5 | 54% | 2% | 7 | Search PENTRAXIN3 | Search PENTRAXIN3 |
7 | NEURONAL PENTRAXIN | 5 | 63% | 1% | 5 | Search NEURONAL+PENTRAXIN | Search NEURONAL+PENTRAXIN |
8 | PTX3 PROTEIN | 4 | 67% | 1% | 4 | Search PTX3+PROTEIN | Search PTX3+PROTEIN |
9 | LONG PENTRAXIN 3 | 3 | 60% | 1% | 3 | Search LONG+PENTRAXIN+3 | Search LONG+PENTRAXIN+3 |
10 | NPTX2 | 1 | 50% | 0% | 2 | Search NPTX2 | Search NPTX2 |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | PTX3 | 191 | 74% | 30% | 140 |
2 | LONG PENTRAXIN | 183 | 84% | 22% | 100 |
3 | RECOGNITION RECEPTOR PTX3 | 108 | 85% | 12% | 57 |
4 | REGULATES TISSUE FACTOR | 76 | 88% | 8% | 36 |
5 | HUMORAL INNATE IMMUNITY | 42 | 83% | 5% | 24 |
6 | LONG PENTRAXIN 3 | 28 | 81% | 4% | 17 |
7 | CLOTTING ACTIVATION | 23 | 64% | 5% | 23 |
8 | LONG PENTRAXIN PTX3 | 21 | 30% | 13% | 59 |
9 | PENTAXIN FAMILY | 21 | 90% | 2% | 9 |
10 | AMYLOID P COMPONENT | 16 | 15% | 22% | 100 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Long Pentraxin 3: Experimental and Clinical Relevance in Cardiovascular Diseases | 2013 | 15 | 92 | 67% |
The long pentraxin PTX3 at the crossroads between innate immunity and tissue remodelling | 2011 | 29 | 54 | 85% |
Pentraxins in innate immunity: lessons from PTX3 | 2011 | 46 | 106 | 58% |
The yin-yang of long pentraxin PTX3 in inflammation and immunity | 2014 | 4 | 72 | 81% |
The long pentraxin PTX3 as a prototypic humoral pattern recognition receptor: interplay with cellular innate immunity | 2009 | 65 | 65 | 68% |
The Long Pentraxin PTX3: A Modulator of the Immunoinflammatory Response in Atherosclerosis and Cardiovascular Diseases | 2010 | 49 | 59 | 75% |
Pentraxins and Atherosclerosis: The Role of PTX3 | 2011 | 20 | 108 | 68% |
Pentraxin 3(PTX 3): An Endogenous Modulator of the Inflammatory Response | 2012 | 16 | 76 | 53% |
Interactions of the humoral pattern recognition molecule PTX3 with the complement system | 2012 | 11 | 58 | 66% |
Pentraxins as a key component of innate immunity | 2006 | 92 | 48 | 63% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | L SACCO CLIN SCI | 3 | 35% | 1.7% | 8 |
2 | SEZ PATOL IMMUNOL | 3 | 100% | 0.6% | 3 |
3 | IDET | 3 | 32% | 1.5% | 7 |
4 | IRCCS REGINA ELENA | 2 | 67% | 0.4% | 2 |
5 | LOCALITA LA FAGIANERIA | 2 | 67% | 0.4% | 2 |
6 | RIC IMMUNOL INFIAMMAZ | 1 | 100% | 0.4% | 2 |
7 | ECCELLENZA INNOVAZ DIAGNOST TER EUT | 1 | 22% | 0.9% | 4 |
8 | SOLOMON SNYDER NEUROSCI | 1 | 13% | 1.3% | 6 |
9 | DIBIT 3A1 | 1 | 33% | 0.4% | 2 |
10 | IST CLIN MED GEN EMATOL IMMUNOL CLIN | 1 | 33% | 0.4% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000165906 | SERUM AMYLOID P COMPONENT//PENTRAXIN//MODIFIED C REACTIVE PROTEIN |
2 | 0.0000064706 | ASPERGILLUS FUMIGATUS//UNITE ASPERGILLUS//MOL PL MICROBIOL |
3 | 0.0000061630 | URINARY TRYPSIN INHIBITOR//BIKUNIN//ULINASTATIN |
4 | 0.0000048881 | NEUTROPHIL EXTRACELLULAR TRAPS//NEUTROPHIL EXTRACELLULAR TRAP//NETOSIS |
5 | 0.0000044364 | C REACTIVE PROTEIN//HIGH SENSITIVITY C REACTIVE PROTEIN//CARDIOVASC DIS PREVENT |
6 | 0.0000037267 | MFG E8//APOPTOTIC CELLS//CELL CLEARANCE |
7 | 0.0000035473 | FN14//TWEAK//STWEAK |
8 | 0.0000033764 | HMC05//HEBEI PROV PEOPLES HOSP//DIPARTIMENTO CHIRURG GEN PARIDE STEFANINI |
9 | 0.0000032736 | NEURITIN//ARG31//ACTIVITY REGULATED CYTOSKELETON ASSOCIATED PROTEIN |
10 | 0.0000030094 | SECRETOME//90K MAC 2BP//90K |